Apixaban in bridge to transplant and destination LVAD ‐ rationale and study design: the ApixiVAD trial
ConclusionsA positive outcome in the ApixiVAD study would provide the basis for future, larger, pivotal anticoagulation trials in LVAD patients.
Source: ESC Heart Failure - Category: Cardiology Authors: Bruno Schnegg,
Ricardo Deveza,
Christopher Hayward Tags: Study Design Source Type: research
More News: Bleeding | Cardiology | Heart | Heart Failure | Heart Transplant | Study | Transplant Surgery | Transplants